Cargando…
Efficacy of bosentan in patients with refractory thromboangiitis obliterans (Buerger disease): A case series and review of the literature
The cornerstone of therapy in thromboangiitis obliterans (TAO) is complete abstinence from tobacco. In addition to discontinuation of cigarette smoking, very few pharmacological and surgical options of controversial efficacy are available to date. New therapeutic options with greater efficacy are cl...
Autores principales: | Narváez, Javier, García-Gómez, Carmen, Álvarez, Lorenzo, Santo, Pilar, Aparicio, María, Pascual, María, López de Recalde, Mercè, Borrell, Helena, Nolla, Joan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134796/ https://www.ncbi.nlm.nih.gov/pubmed/27902617 http://dx.doi.org/10.1097/MD.0000000000005511 |
Ejemplares similares
-
Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan
por: De Haro, Joaquin, et al.
Publicado: (2012) -
Thromboangiitis obliterans (Buerger's disease)
por: Arkkila, Perttu ET
Publicado: (2006) -
Thromboangiitis obliterans (Buerger's disease)
por: Rivera-Chavarría, Ignacio J., et al.
Publicado: (2016) -
Thromboangiitis Obliterans (Buerger's Disease)
por: Sinclair, Nicholas R., et al.
Publicado: (2015) -
Thromboangiitis obliterans (Buerger disease)
por: Seebald, Jessica, et al.
Publicado: (2015)